Collegium Pharmaceutical, Inc. Payments of Stock Issuance Costs
Collegium Pharmaceutical, Inc. (COLL) reported Payments of Stock Issuance Costs of $30.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2021-02-25
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for the quarter ending 2018-06-30 was $0.00.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for the quarter ending 2018-03-31 was $30.00K, a 94.30% decline year-over-year.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for fiscal 2018 was $30.00K, a 97.50% decline from fiscal 2017.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for fiscal 2017 was $1.20M, a 41.78% increase from fiscal 2016.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for fiscal 2016 was $845.00K, a 64.91% decline from fiscal 2015.
- Collegium Pharmaceutical, Inc. payments of stock issuance costs for fiscal 2015 was $2.41M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $30.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $30.00K 10-Q · filed 2019-11-06 | $721.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $30.00K 10-Q · filed 2019-08-07 | $721.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.14M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $30.00K 10-Q · filed 2019-05-08 | $721.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.14M derived: sum of 3 quarters · filed 2020-02-27 | $702.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $691.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.11M derived: sum of 2 quarters · filed 2020-02-27 | $672.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.20M 10-K · filed 2020-02-27 |
| 2017-09-30 | $420.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$19.00K derived: sum of 2 quarters · filed 2018-08-08 | $507.00K 10-Q · filed 2017-11-08 | $826.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-06-30 | -$439.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $87.00K 10-Q · filed 2018-08-08 | $406.00K derived: sum of 3 quarters · filed 2018-08-08 | $406.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $526.00K 10-Q · filed 2017-05-10 | $845.00K derived: sum of 2 quarters · filed 2017-05-10 | $845.00K derived: sum of 3 quarters · filed 2017-11-08 | |
| 2016-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $319.00K derived: sum of 2 quarters · filed 2017-11-08 | $845.00K 10-K · filed 2017-03-10 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $526.00K 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $526.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $2.41M 10-K · filed 2017-03-10 | |||
| 2015-03-31 | $193.00K 10-Q/A · filed 2015-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |